HemoShear Therapeutics
Biotechnology, Health Care, Medical
Founded in 2008-01-01
Charlottesville, Virginia, United States
For Profit
About HemoShear Therapeutics
HemoShear Therapeutics develops new treatments for patients with rare metabolic disorders. It creates human-relevant systems to accurately replicate the biology of organ systems and diseases for use throughout drug discovery and development. They work strategically in partnerships with pharmaceutical, biotechnology, and medical device companies. It generates meaningful human response data to increase confidence in decision-making, reduce the risk of costly failures, and identify efficacious therapies.
Company Metrics
- Employees: 11-50
- Monthly Visits: None
- Tech Stack: 15 active products
Financial Information
- Estimated Revenue: $1M to $10M
- Total Funding: 60145000 USD
- Last Funding: 40000000 USD (Series A)
- Funding Status: Early Stage Venture
Technology Stack
HemoShear Therapeutics actively uses 15 products in their tech stack.
Market Presence
Industries: Biotechnology, Health Care, Medical
Headquarters: Charlottesville, Virginia, United States